ENTITY
SHR-A2009
SHR-A2009
PulseAugur coverage of SHR-A2009 — every cluster mentioning SHR-A2009 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-08-04 product_launch Hengrui Medicine's subsidiaries received approval for clinical trials for SHR-A2009 and Adebelimumab injection. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Huayuan Holdings secures 90M yuan stock buyback financing
Huayuan Holdings has secured a specialized financing of up to 90 million yuan from the Industrial and Commercial Bank of China for the purpose of repurchasing its own stock. This loan, with a three-year term, is exclusi…
-
Hengrui Medicine drug trials approved; DeepSeek tops global API calls
Hengrui Medicine has received approval for clinical trials for its SHR-A2009 drug and Adebelimumab injection. The company's subsidiaries, Suzhou Shengdiya Biopharmaceutical and Shanghai Shengdi Biopharmaceutical, will c…